Literature DB >> 32440821

Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses.

Xin Pan1, Wei Liu2, Yi Chai2, Libo Hu2, Junhua Wang1, Yuqi Zhang3.   

Abstract

Atypical teratoid/rhabdoid tumor (ATRT) is a devastating intracranial tumor in children. Currently, its molecular mechanisms cannot be studied effectively because patient samples are limited, and many factors are involved in its pathogenesis. In this study, we analyzed three gene expression profile data sets obtained from the Gene Expression Omnibus (GEO) database to identify genes that participate in ATRT. The datasets were integrated and analyzed using the RobustRankAggreg method to screen for differentially expressed genes (DEGs). We identified 197 DEGs, including 94 downregulated and 103 upregulated genes which were then used for gene set enrichment analysis. The results showed that the downregulated genes were mainly enriched in synaptic vesicle cycle, nicotine addiction, and GABAergic synapse, whereas the upregulated genes were enriched in the cell cycle, p53 signaling pathway, and cellular senescence. Consistent with these results, gene set enrichment analysis showed that E2F targets, G2M checkpoints, and MYC targets were significantly enriched in datasets. Protein-protein interaction (PPI) network revealed that CDK1, CCNA2, BUB1B, CDC20, KIF11, KIF20A, KIF2C, NCAPG, NDC80, NUSAP1, PBK, RRM2, TPX2, TOP2A, and TTK were hub genes. NetworkAnalyst algorithm was used to predict the transcription factor (TF), and the results showed that MYC, SOX2, and KDM5B could regulate these hub genes. In conclusion, the present study brings a new perspective of ATRT pathogenesis and the strategy targeted to cell cycle related gene may be promising treatments for the disease.

Entities:  

Keywords:  Atypical teratoid/rhabdoid tumor; Bioinformatics analyses; Differentially expressed genes; Therapeutic target

Mesh:

Year:  2020        PMID: 32440821     DOI: 10.1007/s12031-020-01587-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

Review 1.  Transcription-independent functions of MYC: regulation of translation and DNA replication.

Authors:  Michael D Cole; Victoria H Cowling
Journal:  Nat Rev Mol Cell Biol       Date:  2008-08-13       Impact factor: 94.444

Review 2.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

Review 3.  Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

Authors:  Michael C Frühwald; Jaclyn A Biegel; Franck Bourdeaut; Charles W M Roberts; Susan N Chi
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

Review 4.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

5.  Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.

Authors:  Eric M Jackson; Angela J Sievert; Xiaowu Gai; Hakon Hakonarson; Alexander R Judkins; Laura Tooke; Juan Carlos Perin; Hongbo Xie; Tamim H Shaikh; Jaclyn A Biegel
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

6.  Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M Cell cycle transition by a traditional Chinese medicine recipe.

Authors:  Su Su Thae Hnit; Mu Yao; Chanlu Xie; Guangbo Ge; Ling Bi; Shenyi Jin; Lijing Jiao; Ling Xu; Lina Long; Hong Nie; Yu Jin; Linda Rogers; Natalka Suchowerska; Matthew Wong; Tao Liu; Paul De Souza; Zhong Li; Qihan Dong
Journal:  J Ethnopharmacol       Date:  2019-12-29       Impact factor: 4.360

7.  Positive expression of KIF20A indicates poor prognosis of glioma patients.

Authors:  Jia Duan; Wei Huang; Haiping Shi
Journal:  Onco Targets Ther       Date:  2016-11-02       Impact factor: 4.147

8.  Identification of key candidate genes and biological pathways in bladder cancer.

Authors:  Xin Gao; Yinyi Chen; Mei Chen; Shunlan Wang; Xiaohong Wen; Shufang Zhang
Journal:  PeerJ       Date:  2018-12-04       Impact factor: 2.984

9.  High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.

Authors:  Qin Jin; Yanfeng Dai; Yan Wang; Shu Zhang; Gang Liu
Journal:  J Clin Pathol       Date:  2019-02-28       Impact factor: 3.411

10.  E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2.

Authors:  Yubin Feng; Lanlan Li; Yan Du; Xiaoqing Peng; Feihu Chen
Journal:  J Cell Mol Med       Date:  2020-01-14       Impact factor: 5.310

View more
  4 in total

1.  Genetic and Clinical Characterization of HOXB2 in Glioma.

Authors:  Xin Pan; Wei Liu; Yi Chai; Junhua Wang; Yuqi Zhang
Journal:  Onco Targets Ther       Date:  2020-10-14       Impact factor: 4.147

2.  microRNA-139-3p Inhibits Malignant Behaviors of Laryngeal Cancer Cells via the KDM5B/SOX2 Axis and the Wnt/β-Catenin Pathway.

Authors:  Yifei Ma; Zili Chen; Guodong Yu
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

3.  Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma.

Authors:  Kang An; Yuehan Zhang; Yingjiao Liu; Shengxi Yan; Zhaowei Hou; Meng Cao; Guangkuo Liu; Congcong Dong; Juncha Gao; Gaifang Liu
Journal:  Oncol Rep       Date:  2020-07-07       Impact factor: 3.906

Review 4.  A mini-review of the role of condensin in human nervous system diseases.

Authors:  Du Pang; Shengping Yu; Xuejun Yang
Journal:  Front Mol Neurosci       Date:  2022-08-04       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.